Category RESEARCH

BioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

BioMed Realty and CordenPharma Colorado Expand Peptide Development Capacity with New Facility in Boulder BioMed Realty, a leading private owner and operator of real estate dedicated to the life sciences, technology, and innovation sectors, has announced a major new partnership…

Read MoreBioMed Realty & CordenPharma Expand Peptide Lab at LEED Gold Facility in Boulder

NEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

New Study in NEJM Highlights Potential Disease-Modifying Treatment for Dravet Syndrome Biotechnology company Stoke Therapeutics and global neuroscience firm Biogen have announced the publication of important new research on the investigational medicine zorevunersen in the prestigious medical journal The New…

Read MoreNEJM Publishes First Evidence of Disease Modification in Dravet Syndrome

Forma Life Sciences Launches U.S.-Based Oral Solid Dosage CDMO in Irvine, California

Forma Life Sciences, Inc. has officially launched as an independent, operator-owned contract development and manufacturing organization (CDMO) dedicated to oral solid dosage formulation development, clinical manufacturing, and commercial drug product production in the United States. Headquartered in Irvine, the company…

Read MoreForma Life Sciences Launches U.S.-Based Oral Solid Dosage CDMO in Irvine, California

PHCbi Introduces LiCellGrow™ Cell Expansion System to Advance Efficient, High-Quality Cell and Gene Therapy Manufacturing

Introduction to PHCbi’s Latest Innovation in Cell Expansion PHC Corporation’s Biomedical Division (PHCbi), headquartered in Tokyo’s Chiyoda-ku district and led by President Nobuaki Nakamura, has announced the launch of its innovative cell expansion system, LiCellGrow™. As a subsidiary of PHC…

Read MorePHCbi Introduces LiCellGrow™ Cell Expansion System to Advance Efficient, High-Quality Cell and Gene Therapy Manufacturing

Imagion Biosystems Files IND with FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent

Imagion Biosystems Advances Precision Cancer Imaging with FDA IND Filing for MagSense® Phase 2 Trial Imagion Biosystems, a molecular imaging company focused on transforming cancer detection and diagnosis, has announced a significant regulatory milestone with the submission of an Investigational…

Read MoreImagion Biosystems Files IND with FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent

Options Establishes Benchmark for Liquid-Cooled High-Density Infrastructure as a Managed Service in Equinix NY5

Options Technology Deploys Cutting-Edge Liquid-Cooled High-Density Cage at Equinix NY5, Pioneering the Future of Financial Services Infrastructure Options Technology (Options), a global leader in high-performance infrastructure for the financial services sector, has announced the deployment of its advanced liquid-cooled high-density…

Read MoreOptions Establishes Benchmark for Liquid-Cooled High-Density Infrastructure as a Managed Service in Equinix NY5